Dimethyl fumarate Mylan 유럽 연합 - 불가리아어 - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - диметил фумарат - Множествена Склероза, Рецидивно-Ремиттирующее - Имуносупресори - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma 유럽 연합 - 불가리아어 - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - диметил фумарат - Множествена Склероза, Рецидивно-Ремиттирующее - Имуносупресори - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva 유럽 연합 - 불가리아어 - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - диметил фумарат - multiple sclerosis, relapsing-remitting; multiple sclerosis - Имуносупресори - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord 유럽 연합 - 불가리아어 - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - диметил фумарат - multiple sclerosis, relapsing-remitting; multiple sclerosis - Имуносупресори - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Neuraxpharm 유럽 연합 - 불가리아어 - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - диметил фумарат - Множествена Склероза, Рецидивно-Ремиттирующее - Имуносупресори - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.